Cargando…
Pre-treatment clinical features in central retinal vein occlusion that predict visual outcome following intravitreal ranibizumab
BACKGROUND: Predicting how patients with central retinal vein occlusion (CRVO) will respond to intravitreal anti-VEGF is challenging. The purpose of this study was to identify pre-treatment clinical features in CRVO that predict visual acuity (VA) following intravitreal ranibizumab. METHODS: Medical...
Autores principales: | Brogan, Kerr, Precup, Monica, Rodger, Amanda, Young, David, Gilmour, David Francis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807839/ https://www.ncbi.nlm.nih.gov/pubmed/29426292 http://dx.doi.org/10.1186/s12886-018-0701-x |
Ejemplares similares
-
Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion
por: Dogan, Emine, et al.
Publicado: (2018) -
Intravitreal ranibizumab improves macular sensitivity in patients with central retinal vein occlusion and macula edema
por: Otawa, Taro, et al.
Publicado: (2022) -
Visual Functions Affecting Vision-Related Quality of Life Following Intravitreal Ranibizumab Therapy for Central Retinal Vein Occlusion
por: Murakami, Tomoya, et al.
Publicado: (2022) -
Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA
por: Nghiem-Buffet, S, et al.
Publicado: (2017) -
Comparison of Intravitreal Dexamethasone Implant and Intravitreal Ranibizumab Efficacy in Younger Patients with Branch Retinal Vein Occlusion
por: Ozcift, Seda Gurakar, et al.
Publicado: (2023)